Regarding the strengths, we studied a homogeneous cohort of IBD patients with no recognized causes of QTc prolongation, the controls were age- and sex-matched, and CRP was used as an objective marker of systemic inflammation. The gene discussed is CRP; the disease is inflammatory bowel disease.